Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Immutep (ASX:IMM): Dual Checkpoint Immunotherapy Achieves in Frontline Oncology

From a broader commercial perspective, Immutep Ltd operates as a specialized life sciences enterprise focused on addressing substantial unmet medical needs, clinical inefficiencies, and therapeutic gaps across global healthcare systems. The group's foundational commercialAssetsand scientific programs are protected by a comprehensive international intellectual property …

Aditi Sarkar | 02 November 2026

Botanix Pharmaceuticals (ASX:BOT) — Commercial Pharmacy Penetration Drives Dermatology Focus

From a broader commercial perspective, Botanix Pharmaceuticals Limited operates as a specialized life sciences enterprise focused on addressing substantial unmet medical needs, clinical inefficiencies, and therapeutic gaps across global healthcare systems. The group's foundational commercialAssetsand scientific programs are protected by a comprehensive international intellectual …

Aditi Sarkar | 02 November 2026

Imugene (ASX:IMU): Oncolytic Virotherapy and CAR-T Progress Means for Cancer Patients

From a broader commercial perspective, Imugene Ltd operates as a specialized life sciences enterprise focused on addressing substantial unmet medical needs, clinical inefficiencies, and therapeutic gaps across global healthcare systems. The group's foundational commercialAssetsand scientific programs are protected by a comprehensive international intellectual property …

Aditi Sarkar | 02 November 2026

Impedimed (ASX:IPD) — Clinical Guideline Adoption Accelerates Hospital SOZO Deployment

From a broader commercial perspective, Impedimed Limited operates as a specialized life sciences enterprise focused on addressing substantial unmet medical needs, clinical inefficiencies, and therapeutic gaps across global healthcare systems. The group's foundational commercialAssetsand scientific programs are protected by a comprehensive international intellectual property …

Aditi Sarkar | 02 November 2026

Vitura Health (ASX:VIT): Digital Prescribing Platform Achieves for Healthcare Access

From a broader commercial perspective, Vitura Health Limited operates as a specialized life sciences enterprise focused on addressing substantial unmet medical needs, clinical inefficiencies, and therapeutic gaps across global healthcare systems. The group's foundational commercialAssetsand scientific programs are protected by a comprehensive international intellectual …

Aditi Sarkar | 02 November 2026

Tissue Repair (ASX:TRP) — Phase 3 Chronic Wound Healing Data Represents a Commercial Turning Point

From a broader commercial perspective, Tissue Repair Ltd operates as a specialized life sciences enterprise focused on addressing substantial unmet medical needs, clinical inefficiencies, and therapeutic gaps across global healthcare systems. The group's foundational commercialAssetsand scientific programs are protected by a comprehensive international intellectual …

Aditi Sarkar | 02 November 2026

Somnomed (ASX:SOM): Direct-to-Dentist Digital Scanning Achieves in Obstructive Sleep Apnea

From a broader commercial perspective, Somnomed Limited operates as a specialized life sciences enterprise focused on addressing substantial unmet medical needs, clinical inefficiencies, and therapeutic gaps across global healthcare systems. The group's foundational commercialAssetsand scientific programs are protected by a comprehensive international intellectual property …

Aditi Sarkar | 02 November 2026

Imagion Biosystems (ASX:IBX) — Magnetic Nanoparticle Technology Rewrites Cancer Staging

From a broader commercial perspective, Imagion Biosystems Ltd. operates as a specialized life sciences enterprise focused on addressing substantial unmet medical needs, clinical inefficiencies, and therapeutic gaps across global healthcare systems. The group's foundational commercialAssetsand scientific programs are protected by a comprehensive international intellectual …

Aditi Sarkar | 02 November 2026

Clarity Pharmaceuticals (ASX:CU6): Targeted Copper Theranostics Mean for Precision Oncology

From a broader commercial perspective, Clarity Pharmaceuticals Ltd. operates as a specialized life sciences enterprise focused on addressing substantial unmet medical needs, clinical inefficiencies, and therapeutic gaps across global healthcare systems. The group's foundational commercialAssetsand scientific programs are protected by a comprehensive international intellectual …

Aditi Sarkar | 02 November 2026

Dimerix (ASX:DXB) — Global Phase 3 Kidney Disease Trial Anchors Nephrology Focus

From a broader commercial perspective, Dimerix Limited operates as a specialized life sciences enterprise focused on addressing substantial unmet medical needs, clinical inefficiencies, and therapeutic gaps across global healthcare systems. The group's foundational commercialAssetsand scientific programs are protected by a comprehensive international intellectual property …

Aditi Sarkar | 02 November 2026
Support

Hi! How can we help you today?

Loading…